Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Caspase 7 - Drugs In Development, 2021
US$ 3,500.00
Caspase 7 - Drugs In Development, 2021 SUMMARY Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) - Caspase-7 (CASP7) is a human protein encoded by...
June 2021
56 pages
Dystrophin (DMD) - Drugs In Development, 2021
US$ 3,500.00
Dystrophin (DMD) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Dystrophin - Drugs In Development, 2021'; Dystrophin (DMD) pipeline Target constitutes close to 57 mol...
June 2021
161 pages
Exportin 1 - Drugs In Development, 2021
US$ 3,500.00
Exportin 1 - Drugs In Development, 2021 SUMMARY Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) pipeline Target constitutes close to 10 molecules. Out of which approximately 10 mo...
June 2021
143 pages
Gonorrhea (Infectious Disease) - Drugs In Development, 2021
US$ 2,000.00
Gonorrhea (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gonorrhea (Infectious Disease) - Drugs In Develo...
June 2021
127 pages
Gorlin Syndrome (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Gorlin Syndrome (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gorlin Syndrome (Oncology) - Drugs In Development, 2...
June 2021
186 pages
Iduronate 2 Sulfatase - Drugs In Development, 2021
US$ 3,500.00
Iduronate 2 Sulfatase - Drugs In Development, 2021 SUMMARY According to the recently published report 'Iduronate 2 Sulfatase - Drugs In Development, 2021'; Iduronate 2 Sulfatase (Alpha L Iduronate Sul...
June 2021
75 pages
Leukotriene A 4 Hydrolase - Drugs In Development, 2021
US$ 3,500.00
Leukotriene A 4 Hydrolase - Drugs In Development, 2021 SUMMARY Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) pipeline Target constitutes close to 6 mol...
June 2021
50 pages
Myocarditis (Cardiovascular) - Drugs In Development, 2021
US$ 2,000.00
Myocarditis (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis (Cardiovascular) - Drugs In Developmen...
June 2021
57 pages
Pressure Ulcers (Dermatology) - Drugs In Development, 2021
US$ 2,000.00
Pressure Ulcers (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pressure Ulcers (Dermatology) - Drugs In Developm...
June 2021
30 pages
Pruritus (Dermatology) - Drugs In Development, 2021
US$ 2,000.00
Pruritus (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pruritus (Dermatology) - Drugs In Development, 2021, pro...
June 2021
221 pages
Restenosis (Cardiovascular) - Drugs In Development, 2021
US$ 2,000.00
Restenosis (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis (Cardiovascular) - Drugs In Development,...
June 2021
40 pages
Tyrosine Protein Kinase Mer - Drugs In Development, 2021
US$ 3,500.00
Tyrosine Protein Kinase Mer - Drugs In Development, 2021 SUMMARY According to the recently published report 'Tyrosine Protein Kinase Mer - Drugs In Development, 2021'; Tyrosine Protein Kinase Mer (Pro...
June 2021
94 pages
16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021
US$ 3,000.00
16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 SUMMARY 16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 provides in depth analysis on 16S Ribosomal RNA (16S rRNA) targeted pipeline...
April 2021
85 pages
23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021
US$ 3,000.00
23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 SUMMARY 23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 provides in depth analysis on 23S Ribosomal RNA (23S rRNA) targeted pipeline...
April 2021
70 pages
